- Home
- SCSC vs LENZ Comparison
SCSC vs LENZ Comparison
Compare SCSC & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCSC | LENZ |
|---|---|---|
| Founded | 1992 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 892.3M | 852.0M |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SCSC | LENZ |
|---|---|---|
| Price | $41.83 | $16.75 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $43.00 | ★ $56.25 |
| AVG Volume (30 Days) | 156.6K | ★ 1.1M |
| Earning Date | 01-29-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.79 | N/A |
| EPS | ★ 3.20 | N/A |
| Revenue | ★ $3,004,880,000.00 | $17,500,000.00 |
| Revenue This Year | $5.96 | N/A |
| Revenue Next Year | $5.06 | $204.72 |
| P/E Ratio | $13.11 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $28.75 | $15.70 |
| 52 Week High | $53.90 | $50.40 |
Technical Indicators
Market Signals| Indicator | SCSC | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 54.02 | 22.73 |
| Support Level | $40.06 | $15.70 |
| Resistance Level | $43.41 | $29.02 |
| Average True Range (ATR) | 1.18 | 2.30 |
| MACD | 0.14 | -1.07 |
| Stochastic Oscillator | 58.21 | 6.68 |
Price Performance
Historical ComparisonAbout SCSC ScanSource Inc.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.